Case reports and literature review Authors: Reem J. Al Argan, MBBS, SB-Med, SF-Endo, FACE, ECNU,∗Safi G. Alqatari, MBBS, MRCPI, MMedSc, CFP (Rheum), Abir H. Al Said, MBBS, SB-Med, CFP (Pulmo.), Raed M. Alsulaiman, MBBS, SB-Med, Abdulsalam Noor, MBBS, SB-Med, ArBIM, SF-Nephro, Lameyaa A. Al Sheekh, MD, SB-med, and Feda’a H. Al Beladi, MD Abstract Introduction: Corona virus disease-2019 (COVID-19) presents […]
Authors: Rouzbeh ShadidiAsilaSetarehMahmoodiaAmirZamaniaAzadehHakakzadehbcElenaJamalid International Journal of Surgery Case Reports Volume 8, November 2021, 106473 Highlights • Patients with COVID-19 sometimes presents with GI symptoms in addition to respiratory symptoms.• Detecting RNA of SARS-CoV-2 in the stool specimen of the patient with COVD-19 has raised the concern of fecal-oral transmission of the virus.• Invasion of the virus […]
Authors: published on The Conversation by Vincent Ho at Western Sydney University. Although we might think of Covid-19 as a respiratory disease, we know it involves the gut. In fact, SARS-CoV-2, the virus that causes Covid-19, enters our cells by latching onto protein receptors called ACE2. And the greatest numbers of ACE2 receptors are in the cells that line the gut. […]
Summary: Ovarian cysts is found among people who get Pfizer BioNTech Covid Vaccine, especially for people who are 30-39 old, and after 30 days of getting the vaccine. The phase IV clinical study analyzes which people get Pfizer BioNTech Covid Vaccine and have Ovarian cysts. It is created by eHealthMe based on reports of 286,220 […]
Authors: EUROPEAN SOCIETY OF CLINICAL MICROBIOLOGY AND INFECTIOUS DISEASES FEBRUARY 11, 2022 New research to be presented at this year’s European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2022, Lisbon, April 23-26) suggests that many of the symptoms connected to post-COVID syndrome (PCC, also known as long COVID) could be linked to the effect of the […]
Authors: Eyad Abuelgasim,Ann Christine Modaragamage Dona,Rajan Singh Sondh,Amer Harky First published: 28 September 2020 https://doi.org/10.1111/dth.14328 Abstract The global pandemic COVID-19 has resulted in significant global morbidity, mortality and increased healthcare demands. There is now emerging evidence of patients experiencing urticaria. We sought to systematically review current evidence, critique the literature, and present our findings. Allowing PRISMA […]
Authors: Dagnia Zeidlickis, Vice President, Communications | zeidlick@cshl.edu | 516-367-8455 A high dose of famotidine, commonly known as Pepcid®, was found to have beneficial effects in adult patients with coronavirus disease 2019 (COVID-19), according to results of an outpatient clinical trial. Patients who took famotidine in this trial experienced a decrease of inflammation within the body and reported earlier […]
Authors: Saima May Sidik 10 February 2022 Massive study shows a long-term, substantial rise in risk of cardiovascular disease, including heart attack and stroke, after a SARS-CoV-2 infection. Even a mild case of COVID-19 can increase a person’s risk of cardiovascular problems for at least a year after diagnosis, a new study1 shows. Researchers found that […]
Here’s how to detox from the COVID spike protein – from the jab or the virus Spike proteins can circulate in your body after infection or injection, causing damage to cells, tissues and organs, but the World Council for Health has compiled a list of medications to prevent this. Thu Dec 23, 2021 – 10:38 […]
